Recro Pharma Inc  

(Public, NASDAQ:REPH)   Watch this stock  
Find more results for William B. Churchill
6.69
-0.46 (-6.43%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.49 - 7.50
52 week 5.01 - 9.88
Open 6.65
Vol / Avg. 33,449.00/83,694.00
Mkt cap 51.56M
P/E     -
Div/yield     -
EPS -0.45
Shares 7.71M
Beta     -
Inst. own 62%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -269.49% -389.55%
Return on average equity - -
CDP Score - -

Address

490 LAPP ROAD
MALVERN, PA 19355
United States - Map
+1-484-3952400 (Phone)
+1-484-3952471 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Recro Pharma, Inc. is a clinical-stage specialty pharmaceutical company. The Company develops non-opioid therapeutics for the treatment of pain, initially in the post-operative setting. The Company�s lead product, an intranasal formulation of Dexmedetomidine (Dex), has completed a placebo controlled trial demonstrating effective pain relief. Its lead product candidate is Dex-IN, its intranasal formulation of Dex. The Company is evaluating multiple formulations of Dex to target a range of pain indications, including cancer pain in addition to post-operative pain. In addition to Dex, it has second alpha -2 agonist candidate under development, Fadolmidine (Fado).

Officers and directors

Wayne B. Weisman J.D. Independent Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Gerri Henwood President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Charles Garner Chief Financial Officer, Chief Business Officer and Treasurer
Age: 38
Bio & Compensation  - Reuters
Randall Mack Senior Vice President - Development, Secretary
Age: 48
Bio & Compensation  - Reuters
Diane Myers Senior Vice President - Regulatory and Quality
Age: 50
Bio & Compensation  - Reuters
Donna M. Nichols Chief Accounting Officer, Corporate Controller
Age: 58
Bio & Compensation  - Reuters
Alfred Altomari Independent Director
Age: 55
Bio & Compensation  - Reuters
William L. Ashton Independent Director
Age: 63
Bio & Compensation  - Reuters
Michael Berelowitz M.D. Independent Director
Age: 69
Bio & Compensation  - Reuters
Winston J. Churchill Jr. Independent Director
Age: 73
Bio & Compensation  - Reuters